The active substances in the Union list should be regularly examined to take account of developments in science and technology. Where there are significant indications that an active substance used in biocidal products or treated articles does not meet the requirements of this Regulation, the Commission should be able to review the approval of the active substance.
Recital 13, Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…
In forcecited 1×
Judgment of the General Court (Fourth Chamber) of 3 July 2024. SBM Développement SAS v European Commission.Decision
Second, it is true that the risk of secondary poisoning was considered acceptable at EU level in the context of the procedure for the approval of the active substance alphachloralose. However, the inclusion of that substance in Annex I to …
3 Jul 2024 · 62022TJ0667